The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension

Mundipharma Pharmaceuticals LimitedPA1688/013/002

Main Information

Trade NameFlutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension
Active SubstancesFluticasone propionate
Formoterol fumarate dihydrate
Dosage FormPressurised inhalation, suspension
Licence HolderMundipharma Pharmaceuticals Limited
Licence NumberPA1688/013/002

Group Information

ATC CodeR03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK11 formoterol and fluticasone


License statusAuthorised
Licence Issued19/10/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back